Evidence map›Paper›PMID 26268454›Full record

ArticleJournal of immunological methods2015

Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas.

Bharathi Krishnan, Chandirasegaran Massilamany, Rakesh H Basavalingappa, Rajkumar A Rajasekaran, Charles Kuszynski, Barbara Switzer, Daniel A Peterson, Jay Reddy

Abstract read
In one paragraph

Article in Journal of immunological methods, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bharathi KrishnanSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, United States.
Chandirasegaran MassilamanySchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, United States.
Rakesh H BasavalingappaSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, United States.
Rajkumar A RajasekaranSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, United States.
Charles KuszynskiNebraska Center for Virology, University of Nebraska-Lincoln, Lincoln, NE 68583, United States.
Barbara SwitzerCollege of Medicine, Dean's Research Laboratory, University of Nebraska Medical Center, Omaha, NE 68918, United States.
Daniel A PetersonDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, United States.
Jay ReddySchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, United States. Electronic address: nreddy2@unl.edu.

Funding

Autoimmunity in the Mediation of Infectious MyocarditisR01HL114669 · NHLBI · UNIVERSITY OF NEBRASKA LINCOLN · PI REDDY, JAY · 2013 to 2016
$1.4M
NHLBI NIH HHS HL114669NHLBI NIH HHS R01 HL114669
6 · The paper itself

Abstract

Antigen-specific, T cell hybridomas are useful to study the cellular, molecular and functional events, but their generation is a lengthy process. Thus, there is a need to develop robust methods to generate the hybridoma clones rapidly in a short period of time. To this end, we have demonstrated a novel approach using major histocompatibility complex (MHC) class II dextramers to generate T cell hybridomas for an autoantigen, proteolipid protein (PLP) 139-151. Using MHC class II dextramers assembled with PLP 139-151 as screening and sorting tools, we successfully obtained mono antigen-specific clones within seven to eight weeks. In conjunction with other T cell markers, dextramers permitted phenotypic characterization of hybridoma clones for their antigen specificity in a single step by flow cytometry. Importantly, we achieved successful fusions using dextramer(+) cells sorted by flow cytometry as a starting population, resulting in direct identification of multiple antigen-specific clones. Characterization of selected clones led us to identify chemokine receptor, CCR4(+) to be expressed consistently, but their cytokine-producing ability was variable. Our work provides a proof-of principle that the antigen-specific, CD4 T cell hybridoma clones can be generated directly using MHC class II dextramers. The availability of hybridoma clones that bind dextramers may serve as useful tools for various in vitro and in vivo applications.

Indexed as

AnimalsAutoantigensCD4-Positive T-LymphocytesCell ProliferationCells, CulturedFemaleFlow CytometryHistocompatibility Antigens Class IIHybridomasMiceMultiprotein ComplexesMyelin Proteolipid ProteinPeptide FragmentsProtein MultimerizationReceptors, Antigen, T-Cell, alpha-betaReceptors, CCR4AutoantigensCCR4 protein, humanHistocompatibility Antigens Class IIMultiprotein ComplexesMyelin Proteolipid Proteinmyelin proteolipid protein (139-151)Peptide FragmentsReceptors, Antigen, T-Cell, alpha-betaReceptors, CCR4Autoreactive T cellsMHC class II dextramersT cell hybridoma

Identifiers

PMID26268454
PMCPMC4651793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.